Larvol Delta - Atossa-Therapeutics-Receives-FDA-Rare-Pediatric-Disease-Designation-for-ZEndoxifen-for-Duchenne-Muscular-Dystrophy

Z-endoxifen - Atossa Therap

https://www.prnewswire.com/news-releases/atossa-therapeutics-receives-fda-rare-pediatric-disease-designation-for-z-endoxifen-for-duchenne-muscular-dystrophy-302638744.html

Dec 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next